<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04863547</url>
  </required_header>
  <id_info>
    <org_study_id>ANRS 0007S SEVASAR</org_study_id>
    <nct_id>NCT04863547</nct_id>
  </id_info>
  <brief_title>Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection</brief_title>
  <acronym>SEVASAR</acronym>
  <official_title>Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ANRS, Emerging Infectious Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ANRS, Emerging Infectious Diseases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The COVID-19 epidemic has now raged for more than a year with more than 100 million&#xD;
      identified cases and nearly 2.5 million deaths worldwide. Since November 2020, we have been&#xD;
      witnessing the emergence of viral variants in different regions of the world. This expected&#xD;
      genetic drift of the virus, but somewhat abrupt since November, raises questions concerning&#xD;
      the characteristics of transmissibility, pathogenicity, sensitivity to possible treatments,&#xD;
      and escape from natural or vaccine immunity. The objective of this study is to find out&#xD;
      whether the new variants of SARS-CoV-2 are associated with particular clinical forms. The&#xD;
      results of this research will provide elements to determine whether the new variants of&#xD;
      SARS-CoV-2 are associated with more severe clinical forms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SEVASAR is a paired cohort study with retrospective data collection:&#xD;
&#xD;
        -  Presentation: patients hospitalized for COVID-19 with SARS-CoV-2 variant 20I / 501Y.V1&#xD;
&#xD;
        -  Not exposed: patients hospitalized for COVID-19 with SARS-CoV-2 corresponding to wild&#xD;
           variants type 20A. EU1 or 20A. EU2&#xD;
&#xD;
      The severity of illness will be compared between pairs. Disease severity will be assessed&#xD;
      according to the following definition: defined by a composite criterion including, at 28 days&#xD;
      after hospital admission: WHO scale &gt;5 /11 levels, (death OR need for invasive ventilation OR&#xD;
      need for high flow ventilation (Optiflex or NIV or CPAP) or high concentration mask. This&#xD;
      event will be taken into account regardless of its time of occurrence between the first day&#xD;
      of the hospitalization studied and D29 after hospital admission.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>To estimate the proportion of Severe disease form</measure>
    <time_frame>between the first day of hospitalization and Day 29</time_frame>
    <description>Percentage of severe form. Severity was defined by a composite criterion including, at Day 28 days from hospital admission: WHO scale &gt;5 /11 levels, (death OR required invasive ventilation OR required high flow ventilation (Optiflex or NIV or CPAP) or high concentration mask.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To estimate the proportion of Mortality</measure>
    <time_frame>Day 29</time_frame>
    <description>Percentage of mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To estimate the proportion of WHO score &gt; 5</measure>
    <time_frame>between the first day of hospitalization and Day 29</time_frame>
    <description>Percentage of WHO score &gt; 5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To estimate the proportion of Patient who received critical care</measure>
    <time_frame>between the first day of hospitalization and Day 29</time_frame>
    <description>Percentage of patients who received critical care</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To estimate the proportion of patients who had invasive ventilation</measure>
    <time_frame>between the first day of hospitalization and Day 29</time_frame>
    <description>Percentage of patients who had invasive ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To estimate the proportion of patients who had high flow oxygen therapy</measure>
    <time_frame>between the first day of hospitalization and Day 29</time_frame>
    <description>Percentage of patients who had high flow oxygen therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between the first day of symptoms and the first day of hospitalization</measure>
    <time_frame>between first day of symptoms and the first day of hospitalization assessed up to one month</time_frame>
    <description>Time between the first day of symptoms and the first day of hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delay between the first day of symptoms and the first day of hospitalization</measure>
    <time_frame>between first day of symptoms and the first day of hospitalization assessed up to one month</time_frame>
    <description>Time between the first day of symptoms and the first day of hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between the first day of symptoms and the severity of disease</measure>
    <time_frame>between first day of symptoms and the severity assessed up to one month</time_frame>
    <description>Time between the first day of symptoms and the severity of disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between the first day of symptoms and mortality</measure>
    <time_frame>between first day of symptoms and mortality assessed up to two month</time_frame>
    <description>Time between the first day of symptoms and mortality</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2200</enrollment>
  <condition>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)</condition>
  <arm_group>
    <arm_group_label>Exposed</arm_group_label>
    <description>Patients hospitalized for COVID-19 with SARS-CoV-2 variant 20I / 501Y.V1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non exposed</arm_group_label>
    <description>Patients hospitalized for COVID-19 to SARS-CoV-2 corresponding to wild type 20A variants. EU1 or 20A. EU2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Data collection</description>
    <arm_group_label>Exposed</arm_group_label>
    <arm_group_label>Non exposed</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with Acute symptomatic COVID PCR+ with screening Hospitalized for acute COVID&#xD;
        between January 1,2021 (or since the implementation of the screening in the center) and&#xD;
        february 28, 2021&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  Acute symptomatic PCR + COVID with screening&#xD;
&#xD;
          -  Hospitalized for acute COVID between 01/01/2021 (or since the setting up of the&#xD;
             screening in the center) and 02/28/2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Opposition to participation&#xD;
&#xD;
          -  Identification of variants other than 20I / 501Y.V1&#xD;
&#xD;
          -  Patients infected with SARS-CoV-2 in a nosocomial context&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier Lescure, Pr</last_name>
    <phone>0140258080</phone>
    <email>xavier.lescure@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume Martin-Blondel, Pr</last_name>
    <phone>0561779699</phone>
    <email>martin-blondel.g@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Amiens Picardie Site Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-luc Schmit, MD</last_name>
      <phone>+33322668813</phone>
      <email>Schmit.Jean-Luc@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-luc Schmit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Andrejak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Dubee, MD</last_name>
      <phone>+33241353930</phone>
      <email>vincent.dubee@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Dubee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>hôpital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugues Cordel, MD</last_name>
      <phone>+33148955421</phone>
      <email>hugues.cordel@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Hugues Cordel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Duc Nguyen, MD</last_name>
      <email>duc.nguyen@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <phone>+33556795679</phone>
    </contact_backup>
    <investigator>
      <last_name>Duc Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise Paré</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92104</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adeline BAUVOIS, MD</last_name>
      <email>adeline.bauvois@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Adeline BAUVOIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Béziers</name>
      <address>
        <city>Béziers</city>
        <zip>34 500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie DERIAZ, MD</last_name>
      <email>sophie.deriaz@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie DERIAZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier métropole Savoie</name>
      <address>
        <city>Chambéry</city>
        <zip>73011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel FORESTIER, MD</last_name>
      <phone>+334 79 96 51 72</phone>
      <email>emmanuel.forestier@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel FORESTIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Châteaubriant Nozay Pouancé</name>
      <address>
        <city>Châteaubriant</city>
        <zip>44 110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal GICQUEL, MD</last_name>
      <phone>+332 40 55 88 88</phone>
      <email>pascal.gicquel@ch-cnp.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal GICQUEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoire Dor De Lastours, MD</last_name>
      <phone>+33171114620</phone>
      <email>victoire.de-lastours@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Victoire Dor De Lastours, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnès Lefort, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Martineau, MD</last_name>
      <phone>+33389124078</phone>
      <email>martin.martinot@ch-colmar.fr</email>
    </contact>
    <investigator>
      <last_name>Martin Martineau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Alpes Léman</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz CHROBOCZEK, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tomasz CHROBOCZEK, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hopsitalier Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amélie Chabrol, MD</last_name>
      <phone>+33161696615</phone>
      <email>amelie.chabrol@chsf.fr</email>
    </contact>
    <investigator>
      <last_name>Amélie Chabrol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal</name>
      <address>
        <city>Creteil</city>
        <zip>94 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie GARRAIT, MD</last_name>
      <phone>+33145175000</phone>
    </contact>
    <investigator>
      <last_name>Valérie GARRAIT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudine TOUBOUL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Henry Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Vindrios, MD</last_name>
      <phone>+331145178109</phone>
      <email>william.vindrios@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>William Vindrios, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Piroth, MD</last_name>
      <phone>+33380295475</phone>
      <email>lionel.piroth@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Lionel D Piroth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Garches</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélien Dihn, MD</last_name>
      <phone>+33147107752</phone>
      <email>aurelien.dinh@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Aurélien Dihn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Davido, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Kremlin Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon BESSIS, MD</last_name>
      <phone>+33145217300</phone>
      <email>simon.bessis@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Simon Bessis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Wilpoz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital SALENGRO</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien POISSY, MD</last_name>
      <phone>+33 3 20 44 59 62</phone>
      <email>Julien.POISSY@chu-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Julien POISSY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Faucher, MD</last_name>
      <phone>+33555055555</phone>
      <email>jean-francois.faucher@unilim.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-François Faucher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Perpoint, MD</last_name>
      <phone>+33472071107</phone>
      <email>thomas.perpoint@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas Perpoint, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier François Quesnay</name>
      <address>
        <city>Mantes-la-Jolie</city>
        <zip>78200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Billy, MD</last_name>
      <phone>+33134974000</phone>
      <email>c.billy@ch-mantes-la-jolie.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe Billy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital André Grégoire</name>
      <address>
        <city>Montreuil</city>
        <zip>93100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillemette FREMONT, MD</last_name>
      <phone>+331 49 20 30 40</phone>
      <email>guillemette.fremont-goudot@ght-gpne.fr</email>
    </contact>
    <investigator>
      <last_name>Guillemette FREMONT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier GROSSI, MD</last_name>
      <phone>+332 28 25 56 15</phone>
      <email>dr.grossi@groupeconfluent.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier GROSSI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Raffi, MD</last_name>
      <phone>+33240083112</phone>
      <email>francois.raffi@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>François Raffi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Le Turnier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>American Hospital of Paris</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <zip>92 200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe RAPP, MD</last_name>
      <phone>+33146412728</phone>
      <email>christophe.rapp@ahparis.org</email>
    </contact>
    <investigator>
      <last_name>Christophe RAPP, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Archet</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique Mondain, MD</last_name>
      <phone>+33492035452</phone>
      <email>mondain.v@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Véronique Mondain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Centre-Bretagne</name>
      <address>
        <city>Noyal-Pontivy</city>
        <zip>56920</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BELLEC, MD</last_name>
      <phone>+332 97 79 00 05</phone>
      <email>Laurent.BELLEC@ch-centre-bretagne.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent BELLEC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier LAUREILLARD, MD</last_name>
      <phone>+33466684149</phone>
      <email>DIDIER.LAUREILLARD@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Didier LAUREILLARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Diaconesses Croix Saint-Simon</name>
      <address>
        <city>Paris</city>
        <zip>75 012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine FEYEUX, MD</last_name>
      <email>DFeyeux@hopital-dcss.org</email>
    </contact>
    <investigator>
      <last_name>Delphine FEYEUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HôpitalSaint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme Pacanowski, MD</last_name>
      <phone>+33149282438</phone>
      <email>jerome.pacanowski@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jérome Pacanowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc Mouthon, MD</last_name>
      <phone>+33158411436</phone>
      <email>luc.mouthon@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Luc Mouthon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Lanternier, MD</last_name>
      <phone>+33144381742</phone>
      <email>fanny.lanternier@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Fanny Lanternier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Lescure, Pr</last_name>
      <phone>+33140258080</phone>
      <email>xavier.lescure@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Lescure, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathan Peiffer-Smadja, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Pialoux, MD</last_name>
      <phone>+33156017412</phone>
      <email>gilles.pialoux@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles Pialoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Molina, MD</last_name>
      <phone>+33142494117</phone>
      <email>jean-michel.molina@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel Molina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diane Ponscarme, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI de Poissy/Saint-Germain-en-Laye</name>
      <address>
        <city>Poissy</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves WELKER, MD</last_name>
      <phone>+33139274125</phone>
      <email>Yves.Welker@ght-yvelinesnord.fr</email>
    </contact>
    <investigator>
      <last_name>Yves WELKER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Perigueux</name>
      <address>
        <city>Périgueux</city>
        <zip>24 019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-benoit ZABBE, MD</last_name>
      <email>jean-benoit.zabbe@ch-perigueux.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-benoit ZABBE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Firouze Banisadr, MD</last_name>
      <phone>+33326787186</phone>
      <email>fbanisadr@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Firouze Banisadr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Chapplain, MD</last_name>
      <phone>+33299284321</phone>
      <email>jean-marc.chapplain@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Marc Chapplain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Tattevin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicoll</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Alexandre, Dr</last_name>
      <phone>+33232888739</phone>
      <email>kevin.alexandre@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Kevin Alexandre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital d'Instruction des Armées Bégin</name>
      <address>
        <city>Saint-Mandé</city>
        <zip>94160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cecile Ficko, MD</last_name>
      <phone>+33143985000</phone>
      <email>cecile.ficko@intradef.gouv.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile Ficko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nouvel Hopital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Lefebvre, MD</last_name>
      <phone>+33388116768</phone>
      <email>nicolas.lefebvre@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas Lefebvre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves Hansmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Lesprit, MD</last_name>
      <phone>+33146252525</phone>
      <email>p.lesprit@hopital-foch.com</email>
    </contact>
    <investigator>
      <last_name>Philippe Lesprit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillame Martin-Blondel, MD</last_name>
      <phone>+33561779117</phone>
      <email>martin-blondel.g@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Guillame Martin-Blondel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Tourcoing</name>
      <address>
        <city>Tourcoing</city>
        <zip>59200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Robineau, MD</last_name>
      <phone>+33320694616</phone>
      <email>olivier.robineau82@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Olivier Robineau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Bernard, MD</last_name>
      <phone>+33247473714</phone>
      <email>louis.bernard@univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Louis Bernard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien SAISON, MD</last_name>
      <email>jsaison@ch-valence.fr</email>
    </contact>
    <investigator>
      <last_name>Julien SAISON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amélie DUREAULT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59 300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas KADER ETTAHAR, MD</last_name>
      <phone>+333 27 14 33 33</phone>
      <email>ettahar-n@ch-valenciennes.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas KADER ETTAHAR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Nancy Brabois</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Goehringer, MD</last_name>
      <phone>+33383154800</phone>
      <email>f.goehringer@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>François Goehringer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bretagne Atlantique</name>
      <address>
        <city>Vannes</city>
        <zip>56 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie GOUSSEFF, MD</last_name>
      <phone>+332 97 01 41 41</phone>
      <email>marie.gousseff@ch-bretagne-atlantique.fr</email>
    </contact>
    <investigator>
      <last_name>Marie GOUSSEFF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny POMMERET, MD</last_name>
      <phone>+331 42 11 42 11</phone>
      <email>fanny.pommeret@gustaveroussy.fr</email>
    </contact>
    <investigator>
      <last_name>Fanny POMMERET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Merad MANSOURIA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal</name>
      <address>
        <city>Villeneuve-Saint-Georges</city>
        <zip>94190</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Carreaux Paz, MD</last_name>
      <phone>+33143862000</phone>
      <email>pauline.caraux-paz@chiv.fr</email>
    </contact>
    <investigator>
      <last_name>Pauline Carreaux Paz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>André Zobda Cabié</name>
      <address>
        <city>Fort-de-France</city>
        <state>Martinique France</state>
        <zip>97200</zip>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André Z Cabié, MD</last_name>
      <phone>+33596559673</phone>
      <email>andre.cabie@chu-martinique.fr</email>
    </contact>
    <investigator>
      <last_name>André Cabié, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Martinique</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

